26. CLINICAL FEATURES AND RISK FACTORS OF PATIENTS WITH INVASIVE PULMONARY ASPERGILLOSIS AT NATIONAL LUNG HOSPITAL FROM 2019 TO 2020
Main Article Content
Abstract
Objective: To describe the clinical features and risk factors of patients with invasive pulmonary Aspergillosis treated at the National Lung Hospital.
Methods: Retrospective descriptive study on 47 patients with invasive pulmonary Aspergillosis, treated at the National Lung Hospital from January 2019 to December 2020.
Results: The average age was 54 ± 14 years old, 59.6% were 18-60 years olds, male/female was 2/1. The most common reasons for being hospitalized are breathless (48.9%) and fever (17%). However, the earliest symptoms of the disease appear 1-3 weeks before admission: Fever (40.4%) and phlegm cough (40.4%). 30/47 (63.8%) patients had host factors for EORTC/ MSG, mainly hematological malignancies (34%) and long-term corticosteroid use (23.4%). Other co-morbidities are diabetes (34%), hypertension (10.6%), and chronic hepatitis (14.9%).
Conclusion: Clinical features of invasive pulmonary Aspergillosis are multiform and non-specific, you have to think about fungal infection in patients with risk factors and have persistent respiratory symptoms that do not improve with common treatment.
Article Details
Keywords
Aspergillus pulmonary, invasive Aspergillosis, clinical, risk factors.
References
and Multi-National Prevalence of Fungal Diseases—
Estimate Precision. J Fungi.3(4), 2017.
[2] Smith JA, Kauffman CA, Pulmonary fungal
infections. Respirology. 17(6):913-926, 2012.
[3] De Pauw B, Walsh TJ, Donnelly JP et al., Revised
Definitions of Invasive Fungal Disease
from the European Organization for Research
and Treatment of Cancer/Invasive Fungal Infections
Cooperative Group and the National Institute of
Allergy and Infectious Diseases Mycoses
Study Group (EORTC/MSG) Consensus Group.
Clin Infect Dis.46(12):1813-1821, 2008.
[4] Webb BJ, Ferraro JP, Rea S et al., Epidemiology
and Clinical Features of Invasive Fungal Infection in
a US Health Care Network. Open Forum
Infect Dis.5(8), 2018.
[5] Nguyễn Thị Như Quỳnh, Đặc điểm lâm sàng,
cận lâm sàng và kết quả điều trị nấm phổi xâm
lấn tại Trung tâm Hô hấp Bệnh viện Bạch Mai.
Luận văn thạc sĩ Đại học Y Hà Nội, 2018.
[6] Tong KB, Lau CJ, Murtagh K et al., The economic
impact of aspergillosis: Analysis of hospital expenditures
across patient subgroups. Int J Infect Dis.13(1):24-36,
2009.
[7] Segal BH, Walsh TJ, Current Approaches to
Diagnosis and Treatment of Invasive Aspergillosis.
Am J Respir Crit Care Med.173(7):707-717, 2006.